Public Profile

CoreRx, Inc.

CoreRx, Inc., a leading player in the pharmaceutical contract development and manufacturing industry, is headquartered in the United States. Founded in 2010, the company has established itself as a trusted partner for pharmaceutical and biotechnology firms, specialising in the development and production of complex drug formulations. With a focus on oral solid dosage forms, CoreRx offers a range of services, including formulation development, analytical testing, and commercial manufacturing. Their commitment to innovation and quality has positioned them as a preferred choice for clients seeking tailored solutions in drug development. CoreRx's notable achievements include a robust portfolio of successful product launches and a reputation for excellence in regulatory compliance, making them a key contributor to the advancement of healthcare solutions globally.

DitchCarbon Score

How does CoreRx, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

23

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

34

Industry Benchmark

CoreRx, Inc.'s score of 23 is lower than 77% of the industry. This can give you a sense of how well the company is doing compared to its peers.

23%

Let us know if this data was useful to you

CoreRx, Inc.'s reported carbon emissions

CoreRx, Inc., headquartered in the US, currently does not have available data on carbon emissions, as no specific emissions figures have been provided. Additionally, there are no documented reduction targets or climate pledges outlined in their initiatives. This absence of data suggests that CoreRx may still be in the early stages of formalising its climate commitments or reporting on its carbon footprint. As the industry increasingly prioritises sustainability, it is essential for companies like CoreRx to establish clear emissions reduction strategies and set measurable targets to align with global climate goals.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. CoreRx, Inc.'s primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for CoreRx, Inc. is in US, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

CoreRx, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Adare Pharma Solutions

US
Pharmaceutical Preparation Manufacturing
Updated about 6 hours ago

Corden Pharma GmbH

DE
Pharmaceutical Preparation Manufacturing
Updated about 6 hours ago

Avara Pharmaceutical Services, Inc.

US
Pharmaceutical Preparation Manufacturing
Updated about 6 hours ago

BioDuro-Sundia

US
Research and development services (73)
Updated about 6 hours ago

Catalent

US
Pharmaceutical Preparation Manufacturing
Updated about 6 hours ago

Frontage Laboratories, Inc.

US
Pharmaceutical Preparation Manufacturing
Updated about 6 hours ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers